Hologic Receives Order
for 17 Selenia Mobile Systems
Hologic has announced that thay have received an order for 17 Selenia digital mammography mobile systems, the fi rst order placed under The Netherlands Breast Cancer Screening Tender. Installation will begin during the course of this summer. More than 50 additional digital mammography systems will be installed under the tender over a four year period. Hologic and their dealer in the Netherlands, Tromp Medical, already have 60 Selenia digital mammography systems sold in The Netherlands – over 75% of the installed base.
Agfa Selected by Canadian e-Health Programme
Agfa HealthCare has announced it has been selected as the vendor of choice by New Brunswick, one of Canada’s provinces, to deliver a Diagnostic Imaging Repository (DI-r). The agreement is a part of the e-Health strategy - One Patient One Record - which will provide the infrastructure and functionality required to capture, store, view and link relevant patient information for its 740,000 residents.
New Brunswick has partnered with Canada Health Infoway, which is contributing $18.2 million to the overall initiative, with the remaining $17.7 million coming from the province. The province expects to implement its One Patient One Record system during the next three years.
Agfa HealthCare will create a Diagnostic Imaging Repository based on its IMPAX® Data Center concept, for consolidating images and radiology reports into a central system. The information can be retained for a patient’s lifetime, and is available in a standardised format, for the use of authorised clinicians. Doctors, nurses and technologists will have secure log-in access to relevant prior patient images, regardless of where they were acquired. Not only will the repository help clinicians make informed decisions about the optimal care given to patients, healthcare facilities can also expect to significantly reduce costs, by for example, avoiding the duplication of imaging exams due to lost paper files.
UK Hospital Chooses New Siemens System
Chelsea and Westminster Hospital NHS Foundation Trust has ordered the newly launched SOMATOM Definition AS and AS+ CT systems from Siemens via the NHS Supply Chain Framework.
The SOMATOM Definition AS and AS were launched at RSNA in late 2007 and into the UK in February. The NHS Supply Chain infrastructure is helping to speed up the process of medical equipment procurement by opening up dialogue between suppliers and Trusts and delivering greater value for money.
The SOMATOM Definition AS and AS+ are CT scanners that adapt to virtually any patient and clinical need. The systems are suitable for routine diagnostic work and complex examinations including oncology, neurology and cardiology.
The Defi nition AS combines an Adaptive Dose Shield, which blocks unnecessary radiation thus ensuring the patient is only exposed to clinically relevant dose; a scan length of up to 200cm and a 78cm gantry opening all resulting in fast and problem-free headto- foot scanning. The Defi nition AS+ takes functionality further, combining extremely fast coverage with up to 128 slices per rotation whilst maintaining delivery of crystal-clear images, free from movement artefacts and showing the fi nest anatomical details.
Philips and MediGuide Enter Into Cooperation for Trial
Philips and MediGuide have started planned clinical trials in the US Columbia New York Presbyterian Hospital using the Philips Integris Allura Flat Detector catheterisation lab integrated with MediGuide’s Medical Positioning System (gMPS) technology and using the MediGuide gMPS-enabled guided measurement catheter (GMC).
The gMPS is intended for intravascular evaluation of coronary anatomy and for use as an adjunct to coronary angiography. It is intended to enable real-time tip positioning and navigation of a gMPS-enabled (equipped with a gMPS sensor) diagnostic or therapeutic invasive device used in coronary or cardiac intervention in the cath lab environment, on either live fl uoroscopy or recorded background.
The gMPS-enabled GMC intravascular device is intended to be used in conjunction with conventional x-ray angiography systems to enable real-time tip positioning and navigation, quantitative length measurement, 3D lumen reconstruction, qualitative 3D foreshortening indication and landmarking, in patients who are candidates for coronary angiography and/or percutaneous coronary intervention.
Draxis Shares to be Acquired for 255 Million Dollars
Organosys and Draxis Health have entered into an agreement whereby a wholly owned subsidiary of Jubilant will acquire all the outstanding common shares of Draxis for approximately $255 million.
Draxis’ board said it expects the transaction to provide operational and technical resources to accelerate the growth of Draxis’ business and its customer base. The transaction will be carried out by way of a statutory plan of arrangement pursuant to the Canada Business Corporations Act and must be approved by the Québec Superior Court and the affi rmative vote of Draxis’ shareholders at a special meeting of shareholders, according to the companies.